Prevention of febrile neutropenia: use of prophylactic antibiotics.

Thirty-day mortality was lower in the levofloxacin group (1.5%) compared with the placebo group (2.3%), but the difference did not reach statistical significance ( Cullen et al , 2005 ; Leibovici et al , 2006 ).

also in 111,027 other papers